Patients with a specific bowel cancer who were given short-course immunotherapy before surgery, instead of post-op chemotherapy, remained cancer-free after nearly three years of follow-up, according
Source: Groundbreaking bowel cancer trial follow-up shows zero relapses
Wow.
Leave a Reply